Source file signed link, expires in 15 minutes
Extracted text 2
Page 1
Go To English Page
No Surat 1639/DIR/IX/2024
Nama Perusahaan Indofarma Tbk.
Kode Emiten INAF
Lampiran 1
Perihal Pemberitahuan Pembatalan Rapat Umum Pemegang Saham Luar Biasa
Pengumuman Pembatalan RUPS
Merujuk pada surat : 928/CRS/IX/2024
Perseroan menyampaikan pembatalan penyelenggaraan Rapat Umum Pemegang Saham pada :
Hari/Tanggal/Waktu : Kamis, 24 Oktober 2024 Waktu : 00:00
Lokasi Penyelenggaraan RUPS (bila sudah dapat : Jakarta
diumumkan dan sesuai iklan)
Tanggal Daftar Pemegang Saham (DPS) yang berhak hadir : 01 Oktober 2024
dalam RUPS
Demikian untuk diketahui.
Hormat Kami,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Nama Pengirim Warjoko Sumedi
Jabatan Corporate Secretary
Tanggal dan Waktu 30-09-2024
Lampiran 1. S.1639 Pemberitahuan Pembatalan RUPSLB ke OJK.pdf
Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 2
Go To Indonesian Page
No 1639/DIR/IX/2024
Issuer Name Indofarma Tbk.
Issuer Code INAF
Attchment 1
Subject Announcement of Cancelation of Extraordinary General Meeting of
Shareholders
Announcement of Cancelation of Shareholders
Refer to the letter No.928/CRS/IX/2024
The Company announces the cancellation of General Meeting of Shareholders will be held at:
Day/Date/Time : Thursday, 24 October 2024 Time : 00:00
Location : Jakarta
Recording date of Shareholders which are entitled to : 01 October 2024
participate in the AGM
Thus to be informed accordingly.
Respectfully,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Sender Name Warjoko Sumedi
Function Corporate Secretary
Date and Time 30-09-2024
Attachment 1. S.1639 Pemberitahuan Pembatalan RUPSLB ke OJK.pdf
This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.